115 related articles for article (PubMed ID: 20673969)
1. Enhanced hemostatic indices in patients with pulmonary arterial hypertension: an observational study.
Can MM; Tanboğa IH; Demircan HC; Ozkan A; Koca F; Keleş N; Sönmez K; Kaymaz C; Serebruany V
Thromb Res; 2010 Oct; 126(4):280-2. PubMed ID: 20673969
[TBL] [Abstract][Full Text] [Related]
2. Current insights on the pathogenesis of pulmonary arterial hypertension.
Perros F; Dorfmüller P; Humbert M
Semin Respir Crit Care Med; 2005 Aug; 26(4):355-64. PubMed ID: 16121311
[TBL] [Abstract][Full Text] [Related]
3. Platelet indices in patients with pulmonary arterial hypertension.
Varol E; Uysal BA; Ozaydin M
Clin Appl Thromb Hemost; 2011; 17(6):E171-4. PubMed ID: 21406414
[TBL] [Abstract][Full Text] [Related]
4. [Novel concepts in the pathobiology of pulmonary arterial hypertension].
Rosenkranz S
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S167-9. PubMed ID: 18814087
[TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular pathobiology of pulmonary arterial hypertension.
Humbert M; Morrell NW; Archer SL; Stenmark KR; MacLean MR; Lang IM; Christman BW; Weir EK; Eickelberg O; Voelkel NF; Rabinovitch M
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):13S-24S. PubMed ID: 15194174
[TBL] [Abstract][Full Text] [Related]
6. Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension.
Peled N; Shitrit D; Fox BD; Shlomi D; Amital A; Bendayan D; Kramer MR
J Rheumatol; 2009 May; 36(5):970-5. PubMed ID: 19369472
[TBL] [Abstract][Full Text] [Related]
7. [The etiopathogenesis of pulmonary hypertension: inflammation, vascular remodeling].
Kayikçioğlu M
Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():5-8. PubMed ID: 20819761
[TBL] [Abstract][Full Text] [Related]
8. The myth of pulmonary Raynaud's phenomenon: the contribution of pulmonary arterial vasospasm in patients with systemic sclerosis related pulmonary arterial hypertension.
Mukerjee D; Yap LB; Ong V; Denton CP; Howells K; Black CM; Coghlan JG
Ann Rheum Dis; 2004 Dec; 63(12):1627-31. PubMed ID: 15547087
[TBL] [Abstract][Full Text] [Related]
9. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
[TBL] [Abstract][Full Text] [Related]
10. [The oxygen kinetic effect of inhaled iloprost in pulmonary artery hypertension and chronic thromboembolic pulmonary hypertension].
Cui N; Yang YH; Xie WM; Ma ZH; Luo L; Wang C
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Jul; 32(7):522-6. PubMed ID: 19954007
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
12. Endothelial progenitor cells in pulmonary arterial hypertension.
Diller GP; Thum T; Wilkins MR; Wharton J
Trends Cardiovasc Med; 2010 Jan; 20(1):22-9. PubMed ID: 20685574
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide and pulmonary arterial pressures in pulmonary hypertension.
Machado RF; Londhe Nerkar MV; Dweik RA; Hammel J; Janocha A; Pyle J; Laskowski D; Jennings C; Arroliga AC; Erzurum SC
Free Radic Biol Med; 2004 Oct; 37(7):1010-7. PubMed ID: 15336317
[TBL] [Abstract][Full Text] [Related]
14. Diagnostics in pulmonary hypertension.
Schannwell CM; Steiner S; Strauer BE
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):591-602. PubMed ID: 18204173
[TBL] [Abstract][Full Text] [Related]
15. Definition, classification, and epidemiology of pulmonary arterial hypertension.
Hoeper MM
Semin Respir Crit Care Med; 2009 Aug; 30(4):369-75. PubMed ID: 19634076
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance-derived 3-dimensional blood flow patterns in the main pulmonary artery as a marker of pulmonary hypertension and a measure of elevated mean pulmonary arterial pressure.
Reiter G; Reiter U; Kovacs G; Kainz B; Schmidt K; Maier R; Olschewski H; Rienmueller R
Circ Cardiovasc Imaging; 2008 Jul; 1(1):23-30. PubMed ID: 19808511
[TBL] [Abstract][Full Text] [Related]
17. [The current view on pathophysiology of pulmonary arterial hypertension].
Cisowska M; Lewczuk J
Pol Merkur Lekarski; 2007 Apr; 22(130):286-90. PubMed ID: 17684928
[TBL] [Abstract][Full Text] [Related]
18. Dehydroepiandrosterone: A new treatment for vascular remodeling diseases including pulmonary arterial hypertension.
Dumas de la Roque E; Savineau JP; Bonnet S
Pharmacol Ther; 2010 May; 126(2):186-99. PubMed ID: 20206649
[TBL] [Abstract][Full Text] [Related]
19. [Mucoviscidosis and precapillary pulmonary hypertension].
Lindemann H
Monatsschr Kinderheilkd; 1987 Nov; 135(11):728-34. PubMed ID: 3323892
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary arterial pulse pressure and mortality in pulmonary arterial hypertension.
Blyth KG; Syyed R; Chalmers J; Foster JE; Saba T; Naeije R; Melot C; Peacock AJ
Respir Med; 2007 Dec; 101(12):2495-501. PubMed ID: 17719764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
